MEETING REPORTER: Barry Linder, MD, at Eyecelerator 2024 unveils the groundbreaking ELM® (iLipid Mobilizer®) technology developed by Eyedetec Medical. This innovative solution brings a new… Read More »Eye News Media
Inviting the public to invest in the revolutionary solution to chronic dry eye disease USA, [April 2, 2024]—Eyedetec Medical, Inc., the pioneers behind ELM® (Eye… Read More »Invest in Eyedetec: Changing the Future of Dry Eye Therapy
Zhaoke Ophthalmology Limited, a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address significant unmet medical needs,… Read More »Zhaoke Ophthalmology Enters into Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer® for the Treatment of Dry Eye Disease
The ELM™ is not currently commercially available for sale in the U.S.